Zbar Brett I W - Net Worth and Insider Trading

Zbar Brett I W Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Zbar Brett I W owns 1 companies in total, including Centessa Pharmaceuticals PLC (CNTA) .

Click here to see the complete history of Zbar Brett I W’s form 4 insider trades.

Insider Ownership Summary of Zbar Brett I W

Ticker	Comapny	Transaction Date	Type of Owner
CNTA	Centessa Pharmaceuticals PLC	2021-05-27	director

Zbar Brett I W Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Zbar Brett I W Ownership Network

Ownership Network List of Zbar Brett I W

No Data

Ownership Network Relation of Zbar Brett I W

Zbar Brett I W Owned Company Details

What does Centessa Pharmaceuticals PLC do?

Who are the key executives at Centessa Pharmaceuticals PLC?

Zbar Brett I W is the director of Centessa Pharmaceuticals PLC. Other key executives at Centessa Pharmaceuticals PLC include Chief People Officer Karen M. Anderson , SVP Regulatory Affairs Harris Rotman , and Chief Medical Officer Antoine Yver .

Centessa Pharmaceuticals PLC (CNTA) Insider Trades Summary

Over the past 18 months, Zbar Brett I W made no insider transaction in Centessa Pharmaceuticals PLC (CNTA). Other recent insider transactions involving Centessa Pharmaceuticals PLC (CNTA) include a net sale of 34,970 shares made by Antoine Yver , a net sale of 41,751 shares made by Harris Rotman , and a net sale of 51,160 shares made by Karen M. Anderson .

In summary, during the past 3 months, insiders sold 51,160 shares of Centessa Pharmaceuticals PLC (CNTA) in total and bought 0 shares, with a net sale of 51,160 shares. During the past 18 months, 135,881 shares of Centessa Pharmaceuticals PLC (CNTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 135,881 shares.

Centessa Pharmaceuticals PLC (CNTA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Centessa Pharmaceuticals PLC Insider Transactions

No Available Data

Zbar Brett I W Mailing Address

Above is the net worth, insider trading, and ownership report for Zbar Brett I W. You might contact Zbar Brett I W via mailing address: C/o Aisling Capital, 888 Seventh Avenue, 30th Floor, New York Ny 10106.

Discussions on Zbar Brett I W

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.